HF
CVRS

HRT Financial’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

HRT Financial’s Portfolio CVRS Stock Details CVRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-52,733
Closed -$44K – 897
2018
Q4 		$44K Buy
+52,733
New +$62.9K 0.01% 538

Other funds holding CVRS

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HRT Financial's CVRS Position: Q1 2019 in Review

HRT Financial sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q1 2019, closing a stake of 52,733 shares — an estimated $44K sold.

HRT Financial first reported a position in CVRS in Q4 2018 and held it in 1 quarter. The position peaked at $44K in Q4 2018. 64 funds tracked by Wall St. Rank hold CVRS as of Q1 2019.

  • HRT Financial reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q1 2019 after selling out during the quarter.
  • HRT Financial sold 52,733 CORINDUS VASCULAR ROBOTICS, INC shares in Q1 2019, an estimated $44K.
  • HRT Financial first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q4 2018 and held it in 1 quarter.
  • HRT Financial's CORINDUS VASCULAR ROBOTICS, INC position peaked at $44K in Q4 2018.
  • 64 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q1 2019.

Based on HRT Financial's 13F filing for Q1 2019, filed 14 May 2019.